HSPB1 and prostate carcinoma: Gene therapy of murine RM-9 prostate cancer cells with the nitroreductase gene (NTR), followed by administration of the pro-drug, Hsp25 and Hsp70 expression was induced and the targeted cells died via a necrosis-like pathway [42].